The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Clinical Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Diagnostic tests analyze biological samples (blood, saliva, urine, skin, etc.) taken from patients. Theydetect and quantify the presence of bacteria, viruses, fungi or parasites as well as substances secreted by the human body – for example by measuring the level of a hormone or a marker specific to a disease.
The global Clinical Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Diagnostics in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Clinical Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Product, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Diagnostics covered in this report include Siemens Healthcare, Sonic Healthcare, Charles River Laboratories, Quest Diagnostics, Bioscientia Healthcare, Bio-Reference Laboratories, ARUP Laboratories, Abbott Laboratories and Labco, etc.
The global Clinical Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Sonic Healthcare
Charles River Laboratories
Quest Diagnostics
Bioscientia Healthcare
Bio-Reference Laboratories
ARUP Laboratories
Abbott Laboratories
Labco
Healthscope
Laboratory Corporation Of America Holdings
Qiagen
Genoptix Medical Laboratory
Genzyme
Clarient
Global Clinical Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Diagnostics market, Segment by Product:
Instruments
Reagents
Others
Global Clinical Diagnostics market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diagnostic tests analyze biological samples (blood, saliva, urine, skin, etc.) taken from patients. Theydetect and quantify the presence of bacteria, viruses, fungi or parasites as well as substances secreted by the human body – for example by measuring the level of a hormone or a marker specific to a disease.
The global Clinical Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Diagnostics in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Clinical Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Product, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Diagnostics covered in this report include Siemens Healthcare, Sonic Healthcare, Charles River Laboratories, Quest Diagnostics, Bioscientia Healthcare, Bio-Reference Laboratories, ARUP Laboratories, Abbott Laboratories and Labco, etc.
The global Clinical Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens Healthcare
Sonic Healthcare
Charles River Laboratories
Quest Diagnostics
Bioscientia Healthcare
Bio-Reference Laboratories
ARUP Laboratories
Abbott Laboratories
Labco
Healthscope
Laboratory Corporation Of America Holdings
Qiagen
Genoptix Medical Laboratory
Genzyme
Clarient
Global Clinical Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Diagnostics market, Segment by Product:
Instruments
Reagents
Others
Global Clinical Diagnostics market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Product, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Clinical Diagnostics
1.1 Clinical Diagnostics Market Overview
1.1.1 Clinical Diagnostics Product Scope
1.1.2 Clinical Diagnostics Market Status and Outlook
1.2 Global Clinical Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Clinical Diagnostics Market Size by Region (2018-2029)
1.4 Global Clinical Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Clinical Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Clinical Diagnostics Market Size (2018-2029)
1.6.1 North America Clinical Diagnostics Market Size (2018-2029)
1.6.2 Europe Clinical Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Clinical Diagnostics Market Size (2018-2029)
1.6.4 Latin America Clinical Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Clinical Diagnostics Market Size (2018-2029)
2 Clinical Diagnostics Market by Product
2.1 Introduction
2.1.1 Instruments
2.1.2 Reagents
2.1.3 Others
2.2 Global Clinical Diagnostics Market Size by Product: 2018 VS 2022 VS 2029
2.2.1 Global Clinical Diagnostics Historic Market Size by Product (2018-2023)
2.2.2 Global Clinical Diagnostics Forecasted Market Size by Product (2024-2029)
2.3 Key Regions Market Size by Product
2.3.1 North America Clinical Diagnostics Revenue Breakdown by Product (2018-2029)
2.3.2 Europe Clinical Diagnostics Revenue Breakdown by Product (2018-2029)
2.3.3 Asia-Pacific Clinical Diagnostics Revenue Breakdown by Product (2018-2029)
2.3.4 Latin America Clinical Diagnostics Revenue Breakdown by Product (2018-2029)
2.3.5 Middle East and Africa Clinical Diagnostics Revenue Breakdown by Product (2018-2029)
3 Clinical Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Clinical Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Clinical Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Clinical Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Clinical Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Clinical Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Clinical Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Clinical Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Clinical Diagnostics Revenue Breakdown by Application (2018-2029)
4 Clinical Diagnostics Competition Analysis by Players
4.1 Global Clinical Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Diagnostics as of 2022)
4.3 Date of Key Players Enter into Clinical Diagnostics Market
4.4 Global Top Players Clinical Diagnostics Headquarters and Area Served
4.5 Key Players Clinical Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Clinical Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens Healthcare
5.1.1 Siemens Healthcare Profile
5.1.2 Siemens Healthcare Main Business
5.1.3 Siemens Healthcare Clinical Diagnostics Products, Services and Solutions
5.1.4 Siemens Healthcare Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Healthcare Recent Developments
5.2 Sonic Healthcare
5.2.1 Sonic Healthcare Profile
5.2.2 Sonic Healthcare Main Business
5.2.3 Sonic Healthcare Clinical Diagnostics Products, Services and Solutions
5.2.4 Sonic Healthcare Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Sonic Healthcare Recent Developments
5.3 Charles River Laboratories
5.3.1 Charles River Laboratories Profile
5.3.2 Charles River Laboratories Main Business
5.3.3 Charles River Laboratories Clinical Diagnostics Products, Services and Solutions
5.3.4 Charles River Laboratories Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Clinical Diagnostics Products, Services and Solutions
5.4.4 Quest Diagnostics Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 Bioscientia Healthcare
5.5.1 Bioscientia Healthcare Profile
5.5.2 Bioscientia Healthcare Main Business
5.5.3 Bioscientia Healthcare Clinical Diagnostics Products, Services and Solutions
5.5.4 Bioscientia Healthcare Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Bioscientia Healthcare Recent Developments
5.6 Bio-Reference Laboratories
5.6.1 Bio-Reference Laboratories Profile
5.6.2 Bio-Reference Laboratories Main Business
5.6.3 Bio-Reference Laboratories Clinical Diagnostics Products, Services and Solutions
5.6.4 Bio-Reference Laboratories Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Reference Laboratories Recent Developments
5.7 ARUP Laboratories
5.7.1 ARUP Laboratories Profile
5.7.2 ARUP Laboratories Main Business
5.7.3 ARUP Laboratories Clinical Diagnostics Products, Services and Solutions
5.7.4 ARUP Laboratories Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 ARUP Laboratories Recent Developments
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Profile
5.8.2 Abbott Laboratories Main Business
5.8.3 Abbott Laboratories Clinical Diagnostics Products, Services and Solutions
5.8.4 Abbott Laboratories Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Laboratories Recent Developments
5.9 Labco
5.9.1 Labco Profile
5.9.2 Labco Main Business
5.9.3 Labco Clinical Diagnostics Products, Services and Solutions
5.9.4 Labco Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Labco Recent Developments
5.10 Healthscope
5.10.1 Healthscope Profile
5.10.2 Healthscope Main Business
5.10.3 Healthscope Clinical Diagnostics Products, Services and Solutions
5.10.4 Healthscope Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Healthscope Recent Developments
5.11 Laboratory Corporation Of America Holdings
5.11.1 Laboratory Corporation Of America Holdings Profile
5.11.2 Laboratory Corporation Of America Holdings Main Business
5.11.3 Laboratory Corporation Of America Holdings Clinical Diagnostics Products, Services and Solutions
5.11.4 Laboratory Corporation Of America Holdings Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Laboratory Corporation Of America Holdings Recent Developments
5.12 Qiagen
5.12.1 Qiagen Profile
5.12.2 Qiagen Main Business
5.12.3 Qiagen Clinical Diagnostics Products, Services and Solutions
5.12.4 Qiagen Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Qiagen Recent Developments
5.13 Genoptix Medical Laboratory
5.13.1 Genoptix Medical Laboratory Profile
5.13.2 Genoptix Medical Laboratory Main Business
5.13.3 Genoptix Medical Laboratory Clinical Diagnostics Products, Services and Solutions
5.13.4 Genoptix Medical Laboratory Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Genoptix Medical Laboratory Recent Developments
5.14 Genzyme
5.14.1 Genzyme Profile
5.14.2 Genzyme Main Business
5.14.3 Genzyme Clinical Diagnostics Products, Services and Solutions
5.14.4 Genzyme Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Genzyme Recent Developments
5.15 Clarient
5.15.1 Clarient Profile
5.15.2 Clarient Main Business
5.15.3 Clarient Clinical Diagnostics Products, Services and Solutions
5.15.4 Clarient Clinical Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Clarient Recent Developments
6 North America
6.1 North America Clinical Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Clinical Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Clinical Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Clinical Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Clinical Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Clinical Diagnostics Market Dynamics
11.1 Clinical Diagnostics Industry Trends
11.2 Clinical Diagnostics Market Drivers
11.3 Clinical Diagnostics Market Challenges
11.4 Clinical Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
